- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare Kotak Global Emerging Market Fund vs ICICI Prudential US Bluechip Equity Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 0.0 | 0.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.62 | 1.99 |
NAV | ₹22.87 | ₹64.72 |
Fund Started | 25 Jul 2007 | 18 Jun 2012 |
Fund Size | ₹90.54 Cr | ₹3348.63 Cr |
Exit Load | Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days | Exit load of 1% if redeemed within 1 month. |
Risk
Very High
Very High
Rating
0.0
0.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.62
1.99
NAV
₹22.87
₹64.72
Fund Started
25 Jul 2007
18 Jun 2012
Fund Size
₹90.54 Cr
₹3348.63 Cr
Exit Load
Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days
Exit load of 1% if redeemed within 1 month.
Returns
1 Year | 13.07% | 22.04% |
3 Year | 1.20% | 12.20% |
5 Year | 6.83% | 15.55% |
1 Year
13.07%
22.04%
3 Year
1.20%
12.20%
5 Year
6.83%
15.55%
Holding Analysis
Equity | 0.00% | 98.27% |
Cash | 100.00% | 1.73% |
Equity
0.00%
98.27%
Cash
100.00%
1.73%
Top Holdings
Top 10 Holdings | - |
|
Top 10 Holdings
-
Name | Assets |
|---|---|
MarketAxess Holdings Inc | 2.86% |
Altria Group Inc | 2.76% |
Bio-Rad Laboratories Inc A | 2.65% |
Gilead Sciences Inc. (USA) | 2.64% |
Corteva Inc. | 2.62% |
Bristol-Myers Squibb Co | 2.54% |
Kenvue Inc. | 2.53% |
International Flavors & Fragrances Inc | 2.50% |
Pfizer INC | 2.50% |
U.S. Bancorp | 2.45% |
Fund Manager
Name | Arjun Khanna | Ritesh Lunawat |
Start Date | 25 Oct 2023 | 28 Dec 2020 |
Name
Arjun Khanna
Ritesh Lunawat
Start Date
25 Oct 2023
28 Dec 2020
About Fund
Description | The scheme aims to invest a greater proportion of assets in overseas mutual funds investing in globally emerging markets funds. T. Rowe Price SICAV, (TGEMF) which is a Luxembourg domiciled Fund, has been identified by Kotak Mutual Fund as the portfolio for the purpose of Kotak Global Emerging Market Fund. | The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies. |
Launch Date | 25 Jul 2007 | 18 Jun 2012 |
Description
The scheme aims to invest a greater proportion of assets in overseas mutual funds investing in globally emerging markets funds. T. Rowe Price SICAV, (TGEMF) which is a Luxembourg domiciled Fund, has been identified by Kotak Mutual Fund as the portfolio for the purpose of Kotak Global Emerging Market Fund.
The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.
Launch Date
25 Jul 2007
18 Jun 2012
